MedPath

ROFERON-A SOLUTION INJ. 9MILLION I.U./0.9ML

ROFERON-A SOLUTION INJ. 9MILLION I.U./0.9ML

Discontinued
DIN Number

02019914

Drug Class

Human

Market Date

Dec 31, 1993

Company
HC

Hoffmann-La Roche Limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02019914
AIG Number0121068006
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
L03AB04 INTERFERON ALFA-2A
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular ,  Subcutaneous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

INTERFERON ALPHA-2AActive
Strength: 9000000 UNIT / .9 ML
Monograph: INTERFERON ALPHA-2A

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.